Fresh number Т. 16, №2 (62)
Analysis of CML treatment outcomes in Ukraine
Prevalence of nutritional risk in a multicenter sample of hospitalized oncological patients in Ukraine: a cross-sectional study using PRONTOAuthors: Zub V.O. Matolinets N.V. Fediaieva S.I. Osynskyi D.S.... Т. 16, №2 (62)
Age-oriented risk stratification model for basal cell carcinoma: relationship between age, skin phototype, and anatomical localization in a single-center studyAuthor:Kovtun L.O. Т. 16, №2 (62)
Radionuclide monitoring and diagnostic algorithm for detection of relevance and metastasis in patients with iodine-negative forms of differentiated thyroid cancerAuthors: Solodiannykova O.I. Danylenko V.V. Bankovska N.V. Т. 16, №2 (62)
Comparative analysis of functional outcomes and quality of life following transoral CO2 laser microsurgery versus definitive radiation therapy in patients with early-stage HPV-associated oropharyngeal cancerAuthors: Fokin H.H. Kravets O.V. Т. 16, №2 (62)
The role of molecular genetic tests in the treatment of ovarian cancer. Folate receptors as an important therapeutic target in modern oncogynecology. Review of the scientific literatureAuthors: Zlenko M.O. Svintsitskyi V.S. Yatsyna O.I. Т. 16, №2 (62)
Functional status of the thyroid gland as a factor modifying the level of PD-L1 expression by tumor cells and immunocompetent T cells of the paratumoral microenvironmentAuthors: Kolomiiets А.А. Lyalkin S.A. Т. 16, №2 (62)
Chemotherapy-induced thrombocytopenia: current management strategies and prospects for the use of eltrombopag in UkraineAuthor:Syvak L.A. Т. 16, №2 (62)
Systemic treatment of locally advanced and metastatic EGFR-mutated NSCLC. What’s new?Т. 16, №2 (62)
Clinical efficacy of dual HER2 blockade in HER2-positive breast cancerAuthors: Martyniuk O.M. Smolanka I.I. Chapyk I.I. Т. 16, №2 (62)
Нові правила формування онкологічного діагнозу
Інноваційне лікування HER2+ раку грудної залози
Topic immunotherapy with 5% imiquimod in complex clinical...